These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5360288)

  • 41. Determination of prekallikrein in human plasma.
    Briseid K; Dyrud OK; Arntzen FC
    Acta Pharmacol Toxicol (Copenh); 1968; 26(5):395-401. PubMed ID: 5755306
    [No Abstract]   [Full Text] [Related]  

  • 42. Immunochemical studies of plasma kallikrein.
    Bagdasarian A; Lahiri B; Talamo RC; Wong P; Colman RW
    J Clin Invest; 1974 Dec; 54(6):1444-54. PubMed ID: 4140197
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endotoxin-induced kinin (bradykinin) formation: activation of Hageman factor and plasma kallikrein in human plasma.
    Pettinger WA; Young R
    Life Sci; 1970 Mar; 9(6):313-22. PubMed ID: 4986289
    [No Abstract]   [Full Text] [Related]  

  • 44. [The content and activity of basic components of kinin system in blood serum of patients with rheumatism].
    Paskhina TS; Iarovaia GA; Laufer AL; Gulikova OM; Trapeznikova SS; Morozova NA; Makarova OV; Tikhomirov IB; Sysoev VF; Mach ES
    Vopr Med Khim; 1970; 16(2):152-61. PubMed ID: 5311053
    [No Abstract]   [Full Text] [Related]  

  • 45. Glucocorticoids and Hageman factor activation of human plasma kallikrein.
    Henningsen SJ; Zachariae H
    J Invest Dermatol; 1970 Mar; 54(3):196-9. PubMed ID: 5436947
    [No Abstract]   [Full Text] [Related]  

  • 46. Inhibition of the adsorption of Hagemen factor (Factor XII) to glass by normal human plasma.
    Saito H; Ratnoff OD; Donaldson VH; Haney G; Pensky J
    J Lab Clin Med; 1974 Jul; 84(1):62-73. PubMed ID: 4858003
    [No Abstract]   [Full Text] [Related]  

  • 47. Glass activated kallikrein from human plasma.
    Henriques OB; Allan L
    Biochem Pharmacol; 1972 Dec; 21(23):3163-9. PubMed ID: 4650638
    [No Abstract]   [Full Text] [Related]  

  • 48. Interrelations between the clotting and kinin systems. Activation of factor VII involving prekallikrein-kallikrein. A review.
    Stormorken H; Gjoennaess H; Laake K
    Haemostasis; 1973-1974; 2(6):245-52. PubMed ID: 4278152
    [No Abstract]   [Full Text] [Related]  

  • 49. [Enzyme activity (monoamine oxidase, histaminase, kallikreinogen) in carcinoids treated with parachlorophenylalanine].
    Fanciullacci M; Curradi C; Di Lollo F; Sicuteri F
    Boll Soc Ital Biol Sper; 1975 Sep; 51(17):1025-30. PubMed ID: 130150
    [No Abstract]   [Full Text] [Related]  

  • 50. [Activation of the kallikrein-kinin system by endotoxin in the experimental shock model of the rat].
    Kühne H; Schaper U; Lehmann B; Dassler S; Scheuch DW
    Z Med Lab Diagn; 1985; 26(2):67-70. PubMed ID: 3887787
    [No Abstract]   [Full Text] [Related]  

  • 51. Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys.
    Bork K; Kleist R; Hardt J; Witzke G
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):325-32. PubMed ID: 19474702
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kallikreinogen-kallikrein enzymatic system in human plasma. Spontaneous and after activation pool determination in healthy boys, through the use of a new kit.
    Vecchiet L; Cacchio M; Cristiano E; Del Boccio G
    Boll Soc Ital Biol Sper; 1979 Jan; 55(1):27-31. PubMed ID: 475914
    [No Abstract]   [Full Text] [Related]  

  • 53. High prekallikrein levels during pregnancy.
    Marcel GA; Caspar C; Sabatier C; Gautray J; Schirar A
    Pathol Biol (Paris); 1975 Dec; 23 suppl():66-8. PubMed ID: 772561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Physiology and pathology of the pancreatic kallikrein-kinin system].
    Takasugi S; Toki N
    Nihon Rinsho; 1980; 38(1):63-9. PubMed ID: 6901533
    [No Abstract]   [Full Text] [Related]  

  • 55. [Determination of kallikreinogen and kallikrein inhibitors in blood plasma].
    Veremiienko KM; Volokhons'kaia LI; Kizim OI; Meged' NF
    Ukr Biokhim Zh; 1974; 46(2):246-51. PubMed ID: 4545315
    [No Abstract]   [Full Text] [Related]  

  • 56. [Carcinoid and the kallikrein-kinin system].
    Werle E; Trautschold I; Schievelbein H
    Klin Wochenschr; 1966 Jun; 44(11):656-7. PubMed ID: 5299633
    [No Abstract]   [Full Text] [Related]  

  • 57. Immune hemolytic transfusion reactions in monkeys: activation of the kallikrein system.
    Lopas H; Birndorf NI; Bell CE; Robboy SJ; Colman RW
    Am J Physiol; 1973 Aug; 225(2):372-9. PubMed ID: 4198615
    [No Abstract]   [Full Text] [Related]  

  • 58. [Diseases caused by kallikrein-kinin-system deficiencies].
    Ikari N; Kato H
    Nihon Rinsho; 1978 Aug; 36(8):2933-7. PubMed ID: 309519
    [No Abstract]   [Full Text] [Related]  

  • 59. Kinetics of kinin release in canine plasma.
    Green JG; Talamo RC; Colman RW
    Am J Physiol; 1974 Apr; 226(4):784-90. PubMed ID: 4207221
    [No Abstract]   [Full Text] [Related]  

  • 60. Plasma kallikrein-kinin system in nonmammalian blood: evolutionary aspects.
    Seki T; Miwa I; Nakajima T; Erdös EG
    Am J Physiol; 1973 Jun; 224(6):1425-30. PubMed ID: 4197183
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.